Disease causing mutants of TDP-43 nucleic acid binding domains are resistant to aggregation and have increased stability and half-life
- 3 March 2014
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 111 (11) , 4309-4314
Abstract
Significance: Adult onset neurodegenerative diseases are viewed as protein destabilization, misfolding, and aggregation diseases. TAR DNA binding protein-43 (TDP-43) protein is strongly associated with many neurological disorders, particularly amyotrophic lateral sclerosis and frontotemporal lobar degeneration. All of the disease-associated TDP-43 mutants tested have been shown to increase TDP-43 half-life and this correlates inversely with the age at which the sufferer first becomes aware of symptoms. Here we show that disease mutations in two TDP-43 nucleic acid binding domains also increase the protein’s half-life and this is commensurate with increased structural stability and resistance to aggregation. Our results are an unusual contrast to other neurodegenerative diseases and provide a potential link between the molecular characteristics of mutant TDP-43 and the symptoms of these debilitating diseases.Keywords
This publication has 66 references indexed in Scilit:
- Ligand binding and aggregation of pathogenic SOD1Nature Communications, 2013
- Spliceosome integrity is defective in the motor neuron diseases ALS and SMAEMBO Molecular Medicine, 2013
- Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43Nature Neuroscience, 2011
- Characterizing the RNA targets and position-dependent splicing regulation by TDP-43Nature Neuroscience, 2011
- TDP‐43 regulates its mRNA levels through a negative feedback loopThe EMBO Journal, 2010
- Exposure of Hydrophobic Surfaces Initiates Aggregation of Diverse ALS-Causing Superoxide Dismutase-1 MutantsJournal of Molecular Biology, 2010
- Small‐angle scattering for structural biology—Expanding the frontier while avoiding the pitfallsProtein Science, 2010
- No evidence for cognitive dysfunction or depression in patients with mild restless legs syndromeMovement Disorders, 2009
- Phosphorylated TDP‐43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosisAnnals of Neurology, 2008
- Protein aggregation and neurodegenerative diseaseNature Medicine, 2004